• Salamzade R, Swaney MH, Kalan LR (2023) Comparative Genomic and Metagenomic Investigations of the Corynebacterium tuberculostearicumSpecies Complex Reveals Potential Mechanisms Underlying Associations To Skin Health and Disease. Microbiology Spectrum 11(1), e03578-22; doi:
  • Starr NL, Steidl O, Smith J, Sandstrom S, Swaney MH, Singh AM, Kalan LR (2023) Mild-moderate atopic dermatitis controlled by medication exhibits similar bacterial taxa to controls, but strain-level effects and virome disruption persist. Journal of Allergy and Clinical Immunology 151(2); doi:
  • Townsend EC, Kalan, LR (2023) The dynamic balance of the skin microbiome across the lifespan. Biochemical Society Transactions; doi: (PDF)
  • Swaney MH, Nelsen A, Kalan, LR (2023) Sweat and Sebum Preferences of the Human Skin Microbiota. Microbiology Spectrum e04180-22; doi:
  • Salamzade R, Cheong JZA, Sandstrom S, Swaney MH, Stubbendieck RM, Starr NL, Currie CR, Singh AN, Kalan LR (2023) Evolutionary investigations of the biosynthetic diversity in the skin microbiome using lsaBGC. Microbial Genomics 9(4); doi: 1099/mgen.0.000988



  • Salamzade R, Swaney MH, Kalan LR (2022) Comparative genomic and metagenomic investigations of the Corynebacterium tuberculostearicum species complex reveals potential mechanisms underlying associations to skin health and disease. Clinical Microbiology 11(1); doi:
  • Nguyen UT, Kalan LR (2022) Forgotten fungi: the importance of the skin mycobiome. Current Opinion in Microbiology 70, 102235; doi:
  • Cheong JZA, Liu A, Rust C, Kalan LR,Gibson A (2022) Robbing Peter to pay Paul: Chlorhexidine gluconate demonstrates short-term efficacy and long-term cytotoxicity. Wound Repair and Regeneration 30(5), 573 – 584; doi:
  • Swaney MH, Sandstrom S, Kalan LR (2022) Cobamide sharing is predicted in the human skin microbiome. mSystems 7(5); doi:
  • Cheong JZA, Irvine JM, Roesemann S, Nora, A, Morgan, CE, Daniele C, Kalan LR, Brennan MB (2022) Ankle brachial indices & anaerobes: Is peripheral vascular disease associated with anaerobic bacteria in diabetic foot ulcers? Therapeutic Advantage in Endocrinology and Metabolism; 13 (1-12) doi: (PDF)
  • Salamzade R, Cheong JZA, Sandstrom S, Swaney MH, Stubbendieck RM, Starr NL, Currie CR, Singh AM, Kalan LR (2022) IsaBGC provides a comprehensive framework for evolutionary analysis of biosynthetic gene clusters within focal taxa. bioRxiv. 2022 June; doi:
  • Kieft K, Adams A, Salamzade R, Kalan L, Anantharaman K (2022) vRhyme enables binning of viral genomes from metagenomes. Nucleic Acids Research 50(14); doi: (PDF)
  • Swaney MH, Kalan LR (2022) Two-for-one: Dual host-microbe functions of  epidermidissph. Cell Host & Microbe 30(3); doi:
  • Starr NL, Steidl O, Smith J, Sandstrom S, Swaney MH, Singh AM, Kalan L (2022) Culturing of bacterial isolates from skin of pediatric atopic dermatitis subjects. The Journal of Allergy and Clinical Immunology 149(2); doi:
  • Steidl O, Starr NL, Smith J, Kalan L, Singh AM (2022) Staphylococcus aureusdisruption of keratinocytes in atopic dermatitis. The Journal of Allergy and Clinical Immunology 149(2); doi:
  • Johnson CJ, Cheong JZA, Shanmuganayagam D, Kalan LR, Nett JE (2022) Modeling Candida auriscolonization on porcine skin ex vivo. Methods in molecular biology, 251-258; doi:



  • Cheong A, Johnson C, Wan H, Liu A, Kernien J, Gibson A, Nett J, Kalan LR (2021) Priority effects dictate community structure and alter virulence of fungal-bacterial biofilms. bioRxiv; doi:
  • Roesemann S, Cheong A, Tanaglia A, Brennan M, Kalan L (2021) Characterizing Host-Microbiome Interactions In Response to Sharp Debridement In Diabetic Foot Ulcers. Wound Repair and Regeneration 29(3). A18-A19.
  • Swaney MH, Kalan LR (2021) 197 Investigation of vitamin B12 sharing within the skin microbiome. Journal of Investigative Dermatology 141(5); doi:
  • Swaney MH, Kalan LR (2021) Living in your skin: Microbes, molecules, and mechanisms. ASM Infection and Immunity 89(4); doi: 1128/IAI.00695-20



  • Campbell AE, McCready-Vangi AR, Uberoi A, Kalan L, Gardner S, Grice E (2020) Staphylococcus aureus virulence acquisition and diabetic wound fate. Wound Repair and Regeneration.
  • Cheong A, Johnson C, Wan H, Nett J, Kalan L (2020) Investigating bacterial-fungal interactions within chronic wound microbiomes. Wound Repair and Regeneration.
  • Bradley CW, Lee FF, Rankin SC, Kalan LR, Horwinski J, Morris DO, Grice EA, Cain CL (2020) The otic microbiota and mycobiota in a referral population of dogs in eastern USA with otitis externa. Veterinary Dermatology; doi:
  • Horton MV, Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, Meudt JJ, Shanmuganayagam D, Kalan LR, Nett JE (2020) Candida auris forms high-burden biofilms in skin niche conditions and on porcine skin. mSphere. 2020 January; doi:



  • Davis SC, Solis M, Gil J, Higa A, Metzger S, and Kalan L (2019) Effects of topical antimicrobial formulations on Pseudomonas aeruginosainfection in a porcine burn wound model. bioRxiv; doi:
  • Deusenbery CB, Kalan L, Meisel M, Garder SE, Grice E, and Spiller K (2019) Human macrophage response to microbial supernatants from diabetic foot ulcers. Wound Repair and Regeneration 27(6), 598-608; doi:
  • Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I, Chen X, Uberoi A, Gardner SE, Grice EA (2019) Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host & Microbe 25(5), 641-655; doi: 1016/j.chom.2019.03.006
  • Uberoi A, Campbell A, Kalan L, Lovins V, White E, Gardener S, Grice EA (2019) 940 Epithelial-microbial crosstalk modifies wound healing outcomes: from shotgun metagenomics to mechanistic understanding. Journal of Investigative Dermatology 139(5); doi:
  • Cheong JZA, and Kalan LR (2019) Wound microbiome update: sequencing and behavior. Wounds International 10(4); (PDF)



2009 – 2018

  • Kalan LR, Brennan MB (2018) The role of the microbiome in nonhealing diabetic wounds. Annals of the New York Academy of Sciences 1435(1), 79-92; doi:
  • Kalan L, Grice EA (2018) Fungi in the wound microbiome. Advances in Wound Care 7(7); doi:
  • Kalan L, Zhou M, Labbie M, Willing B (2017) Measuring the microbiome of chronic wounds with use of a topical antimicrobial dressing – A feasibility study. PLoS ONE; doi:
  • Kalan LR, Pepin DM, Ul-Haq I, Miller SB, Hay ME, Precht RJ (2017) Targeting biofilms of multidrug-resistant bacteria with silver oxynitrate. International Journal of Antimicrobial Agents 49(6), 719-726; doi:
  • Lemire JA, Kalan L, Gugala N, Bradu A, Turner RJ (2017) Silver oxynitrate – an efficacious compound for the prevention and eradication of dual-species biofilms. Biofouling 33(6), 460-469; doi:
  • Lemire J, Chatfield-Reed K, Kalan L, Gugala N, Westersund, Almblad H, Chua G, Turner RJ (2017) Unravelling the myths and mysteries of the antimicrobial agent, silver. The FASEB Journal; doi:
  • Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP, Tyldsley AS, Franciscus CL, Killis SL, Mehta S, Margolis DJ, Grice EA (2016) Temporal stability in chronic wound microbiota is associated with poor healing. Journal of Investigative Dermatology 137(1), 237-244; doi:
  • Kalan L, Gardner SE, Grice EA (2016) Reply to “Understanding the Role of Fungi in Chronic Wounds”. MBio 7(6) e02033-16; doi: (PDF)
  • Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, Grice EA (2016) Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing. MBio 7(5) 201058-16; doi: (PDF)
  • Swanson T, Angel D, Sussman G, Cooper R, Haeslet E, Ouset K, Carville K, Fletcher J, Kalan L, Keast D, Leaper DJ, Schultz G, Black J, Call E (2016) Wound infection in clinical practice: principles of best practice. Wounds International. 2016 December;
  • Zhu XM, Hackl S, Thaker MN, Kalan L, Weber C, Urgast DS, Krupp EM, Brewer A, Vanner S, Szawiola A, Yim G, Feldmann J, Bechthold A, Wright GD, Zechel DL (2015) Biosynthesis of the fluorinated natural product nucleocidin in Streptomyces calvusis dependent on the bldA-specified leu-tRNA(UUA) molecule. ChemBioChem. 2015 November 16(17), 2498-2506; doi:
  • Lemire JA, Kalan L, Bradu A, Turner RJ (2015) Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity. Antimicrobial Agents and Chemotherapy. 2015 June 33(6), 460-469; doi:
  • Frasch HJ, Kalan L, Kilian R, Martin T, Wright GD, Stegmann E (2015) Alternative pathway to a glycopeptide-resistant cell wall in the balhimycin producer Amycolatopsis balhimycina. ACS Infectious Diseases. 2015 May 1(6), 253-261; doi:
  • Thaker MN, Kalan L, Waglechner N, Eshaghi A, Patel SN, Poutanen S, Willey B, Coburn B, McGeer A, Low DE, Wright GD (2015) Vancomycin-variable enterococci can give rise to constitutive resistance during antibiotic therapy. Antimicrobial Agents Chemotherapy. 2015 February 59(3); doi:
  • Yim G, Kalan L, Koteva K, Thaker MN, Waglechner N, Tang I, Wright GD (2014) Harnessing the synthetic capabilities of glycopeptide antibiotic tailoring enzymes: characterization of the UK-68,597 biosynthetic cluster. ChemBioChem. 2014 September 15(17), 2613-2623; doi:
  • Szakacs TA, Kalan L, McConnell MJ, Eshaghi A, Shahinas D, McGeer A, Wright GD, Low DE, Patel SN (2014) Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA Journal of Clinical Microbiology 52(5); doi:
  • Kalan L, Perry J, Koteva K, Thaker M, Wright G (2013) Glycopeptide sulfation evades resistance. Journal of Bacteriology 195(1);doi:
  • Kalan L, Gessner A, Thaker MN, Waglechner N, Zhu X, Szawiola A, Bechthold A, Wright GD, Zechel DL (2013) A cryptic polyene biosynthetic gene cluster in Streptomyces calvusis expressed upon complementation with a functional bldA Chemistry & biology 20(10), 1214-1224; doi:
  • McArthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, Bhullar K, Canova MJ, De Pascale G, Ejim L, Kalan L, King AM, Koteva K, Morar M, Mulvey MR, O’Brien JS, Pawlowski AC, Piddock LJ, Spanogiannopoulos P, Sutherland AD, Tang I, Taylor PL, Thaker M, Wang W, Yan M, Yu T, Wright GD (2013) The comprehensive antibiotic resistance database. Antimicrobial Agents Chemotherapy 57(7), 3348-3357; doi: 10.1128/AAC.00419-13
  • Kalan LR (2012) Exploiting glycopeptide tailoring enzymes as an approach to overcome resistance. Open Access Dissertations and Theses. 2012 October;
  • Shi R, Munger C, Kalan L, Sulea T, Wright GD, Cygler M (2012) Sulfonation of glycopeptide antibiotics by sulfotransferase StaL depends on conformational flexibility of aglycone scaffold. Proceedings of the National Academy of Sciences 109 (29), 11824-11829; doi:
  • D’Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD (2011) Antibiotic resistance is ancient. Nature 477, 457-461; doi:
  • Kalan L, Wright GD (2011) Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Reviews in Molecular Medicine 13; doi: 1017/S1462399410001766
  • Kalan L, Ebert S, Kelly T, Wright GD (2009) Noncanonical vancomycin resistance cluster from Desulfitobacterium hafniense Antimicrobial Agents Chemotherapy 53(7); doi: